Abstract:Objective: To evaluate the effect of the pessary treatment on general anxiety disorder in patients with symptomatic pelvic organ prolapse (POP). Methods: Between December 2018 and January 2020, 213 patients who received the pessary treatment for symptomatic POP in the Peking Union Medical College Hospital (PUMCH) were enrolled in this prospective observational study. Accepting the pessary successfully means that the patient keeping the pessary for 2 weeks were satisfied with it and willing to use it afterwards, or means that the patient having changed a new pessary and keeping it for 2 weeks were satisfied with it and willing to use it afterwards. The questionnaire General Anxiety Disorder-7 (GAD-7) was used to assess the anxiety state of POP patients, including 163 patients who accepted the pessary treatment successfully and 50 patients who failed, before and after the pessary treatment. A score of 10 or more was considered as the moderate or severe anxiety and defined as the anxiety disorder. Patients who accepted the pessary treatment successfully were followed up for 3 months. Results: Before the treatment, the prevalence of anxiety disorders was 20.9% (34 out of 163) for those patients accepting the pessary and that was 20.0% (10 out of 50) for those patients who failed in keeping the pessary, the difference of which were not statistically significant (P=0.896). The difference of demographic data and clinical characteristics between the anxiety disorder group and the non-anxiety disorder group were not statistically significant (P>0.05). After 3 months of the pessary treatment for those patients using the pessary treatment, the prevalence of anxiety disorders dropped to 3.7% (6/163) from 20.9% (P<0.001). The GAD-7 score of patients with anxiety disorders decreased from a median of 16.0 (12.5, 21.0) before the treatment to 1.0 (0, 4.0) after the treatment, and the difference was statistically significant (P<0.001). Conclusion: Around 20% POP patients receiving pessary treatment had the moderate or severe general anxiety disorder. After 3 months of using the pessary treatment, the prevalence of anxiety disorders in POP patients had dropped significantly.

Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years

Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women

Factors Associated with Long-Term Pessary Use in Women with Symptomatic Pelvic Organ Prolapse

Clinical Study on Silicone Pessary in the Treatment of Pelvic Organ Prolapse

Impacts of Pessary on the Clinical Effect and Life Quality of the Women with Pelvic Organ Prolepses

Predictors for Unsuccessful Pessary Fitting in Women with Symptomatic Pelvic Organ Prolapse: a Prospective Study

Use of Silicon Vaginal Pessary for Treatment of Pelvic Organ Prolapse

Silicone Irregular Hexagon Pessary Versus Polyvinyl Chloride Ring Pessary for Pelvic Organ Prolapse: Randomised Controlled Trial

Depressive Symptoms Affect Outcomes of Pessary Use in Postmenopausal Women with Uterine Prolapse

Silicone pessary treatment of pelvic organ prolapse

Age-stratified Analysis of Long-Term Outcomes of Transvaginal Mesh Repair for Treatment of Pelvic Organ Prolapse.

Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study

Effect of the Pessary Treatment on Anxiety Disorder in Patients with Symptomatic Pelvic Organ Prolapse

Pessary with perineal suture for treatment of pelvic organ prolapse: description and benefit of the technique

Outcomes in Women With Pelvic Organ Prolapse Presenting With Pessary-Related Complications

Understanding Factors That Affect Willingness to Self-Manage a Pessary for Pelvic Organ Prolapse: A Questionnaire-Based Cross-Sectional Study of Pessary-Using Women in the UK

Prolapse surgery versus vaginal pessary in women with symptomatic pelvic organ prolapse: which factors influence the choice of treatment?

Vaginal Cancer: Association with long term use of Pessary in Pelvic Organ Prolapse

[Factors Influencing Therapy Decision in Patients with Severe Pelvic Organ Prolapse].

Six-year Follow-Up Outcomes of the P(LLA-CL)/Fg Bio-Patch for Anterior Vaginal Wall Prolapse Treatment

Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse